120 related articles for article (PubMed ID: 28202391)
1. The Efficacy of Cardiac Anti-miR-208a Therapy Is Stress Dependent.
Eding JE; Demkes CJ; Lynch JM; Seto AG; Montgomery RL; Semus HM; Jackson AL; Isabelle M; Chimenti S; van Rooij E
Mol Ther; 2017 Mar; 25(3):694-704. PubMed ID: 28202391
[TBL] [Abstract][Full Text] [Related]
2. Secretory products from epicardial adipose tissue from patients with type 2 diabetes impair mitochondrial β-oxidation in cardiomyocytes via activation of the cardiac renin-angiotensin system and induction of miR-208a.
Blumensatt M; Fahlbusch P; Hilgers R; Bekaert M; Herzfeld de Wiza D; Akhyari P; Ruige JB; Ouwens DM
Basic Res Cardiol; 2017 Jan; 112(1):2. PubMed ID: 27864612
[TBL] [Abstract][Full Text] [Related]
3. MiRNA-208a and miRNA-208b are triggered in thyroid hormone-induced cardiac hypertrophy - role of type 1 Angiotensin II receptor (AT1R) on miRNA-208a/α-MHC modulation.
Diniz GP; Takano AP; Barreto-Chaves ML
Mol Cell Endocrinol; 2013 Jul; 374(1-2):117-24. PubMed ID: 23623871
[TBL] [Abstract][Full Text] [Related]
4. Metabolic labeling of cardiomyocyte-derived small extracellular-vesicle (sEV) miRNAs identifies miR-208a in cardiac regulation of lung gene expression.
Han C; Yang J; Zhang E; Jiang Y; Qiao A; Du Y; Zhang Q; An J; Sun J; Wang M; Nguyen T; Lal H; Krishnamurthy P; Zhang J; Qin G
J Extracell Vesicles; 2022 Oct; 11(10):e12246. PubMed ID: 36250966
[TBL] [Abstract][Full Text] [Related]
5. Radiation-induced miR-208a increases the proliferation and radioresistance by targeting p21 in human lung cancer cells.
Tang Y; Cui Y; Li Z; Jiao Z; Zhang Y; He Y; Chen G; Zhou Q; Wang W; Zhou X; Luo J; Zhang S
J Exp Clin Cancer Res; 2016 Jan; 35():7. PubMed ID: 26754670
[TBL] [Abstract][Full Text] [Related]
6. Regulation of cardiac miR-208a, an inducer of obesity, by rapamycin and nebivolol.
Gul R; Mahmood A; Luck C; Lum-Naihe K; Alfadda AA; Speth RC; Pulakat L
Obesity (Silver Spring); 2015 Nov; 23(11):2251-9. PubMed ID: 26381051
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-20a inhibits stress-induced cardiomyocyte apoptosis involving its novel target Egln3/PHD3.
Frank D; Gantenberg J; Boomgaarden I; Kuhn C; Will R; Jarr KU; Eden M; Kramer K; Luedde M; Mairbäurl H; Katus HA; Frey N
J Mol Cell Cardiol; 2012 Mar; 52(3):711-7. PubMed ID: 22182733
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure.
Montgomery RL; Hullinger TG; Semus HM; Dickinson BA; Seto AG; Lynch JM; Stack C; Latimer PA; Olson EN; van Rooij E
Circulation; 2011 Oct; 124(14):1537-47. PubMed ID: 21900086
[TBL] [Abstract][Full Text] [Related]
9. Cyclic stretching boosts microRNA-499 to regulate Bcl-2 via microRNA-208a in atrial fibroblasts.
Chua SK; Wang BW; Yu YJ; Fang WJ; Lin CM; Shyu KG
J Cell Mol Med; 2021 Mar; 25(6):3113-3123. PubMed ID: 33605072
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-208a Silencing Attenuates Doxorubicin Induced Myocyte Apoptosis and Cardiac Dysfunction.
Tony H; Yu K; Qiutang Z
Oxid Med Cell Longev; 2015; 2015():597032. PubMed ID: 26137188
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-208a Increases Myocardial Endoglin Expression and Myocardial Fibrosis in Acute Myocardial Infarction.
Shyu KG; Wang BW; Cheng WP; Lo HM
Can J Cardiol; 2015 May; 31(5):679-90. PubMed ID: 25936493
[TBL] [Abstract][Full Text] [Related]
12. Plasma microRNAs serve as biomarkers of therapeutic efficacy and disease progression in hypertension-induced heart failure.
Dickinson BA; Semus HM; Montgomery RL; Stack C; Latimer PA; Lewton SM; Lynch JM; Hullinger TG; Seto AG; van Rooij E
Eur J Heart Fail; 2013 Jun; 15(6):650-9. PubMed ID: 23388090
[TBL] [Abstract][Full Text] [Related]
13. MiR 208a Regulates Mitochondrial Biogenesis in Metabolically Challenged Cardiomyocytes.
Mekala N; Kurdys J; Vicenzi AP; Weiler LR; Avramut C; Vazquez EJ; Ragina N; Rosca MG
Cells; 2021 Nov; 10(11):. PubMed ID: 34831374
[TBL] [Abstract][Full Text] [Related]
14. Silencing of TERT decreases levels of miR-1, miR-21, miR-29a and miR-208a in cardiomyocytes.
Drevytska TI; Nagibin VS; Gurianova VL; Kedlyan VR; Moibenko AA; Dosenko VE
Cell Biochem Funct; 2014 Oct; 32(7):565-70. PubMed ID: 25156787
[TBL] [Abstract][Full Text] [Related]
15. Assessing Anti-miR Pharmacology with miRNA Polysome Shift Assay.
Androsavich JR
Methods Mol Biol; 2017; 1517():103-113. PubMed ID: 27924477
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-208a Dysregulates Apoptosis Genes Expression and Promotes Cardiomyocyte Apoptosis during Ischemia and Its Silencing Improves Cardiac Function after Myocardial Infarction.
Tony H; Meng K; Wu B; Yu A; Zeng Q; Yu K; Zhong Y
Mediators Inflamm; 2015; 2015():479123. PubMed ID: 26688617
[TBL] [Abstract][Full Text] [Related]
17. Paving the Route to Plasma miR-208a-3p as an Acute Cardiac Injury Biomarker: Preclinical Rat Data Supports Its Use in Drug Safety Assessment.
Glineur SF; De Ron P; Hanon E; Valentin JP; Dremier S; Nogueira da Costa A
Toxicol Sci; 2016 Jan; 149(1):89-97. PubMed ID: 26454886
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-297 promotes cardiomyocyte hypertrophy via targeting sigma-1 receptor.
Bao Q; Zhao M; Chen L; Wang Y; Wu S; Wu W; Liu X
Life Sci; 2017 Apr; 175():1-10. PubMed ID: 28286226
[TBL] [Abstract][Full Text] [Related]
19. The emerging role of miR-208a in the heart.
Oliveira-Carvalho V; Carvalho VO; Bocchi EA
DNA Cell Biol; 2013 Jan; 32(1):8-12. PubMed ID: 23121236
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA deep sequencing reveals chamber-specific miR-208 family expression patterns in the human heart.
Kakimoto Y; Tanaka M; Kamiguchi H; Hayashi H; Ochiai E; Osawa M
Int J Cardiol; 2016 May; 211():43-8. PubMed ID: 26974694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
